|
CCDC111 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.6399329650958E-13 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.910200E-02 |
| Stage1-vs-Stage3 |
1.408320E-02 |
| Stage1-vs-Stage4 |
1.955290E-03 |
| Stage2-vs-Stage3 |
8.515000E-01 |
| Stage2-vs-Stage4 |
4.520400E-01 |
| Stage3-vs-Stage4 |
5.139600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.02799999016179E-09 |
| Normal-vs-Asian |
9.8908004009246E-10 |
| Caucasian-vs-AfricanAmerican |
5.373400E-01 |
| Caucasian-vs-Asian |
1.862950E-01 |
| AfricanAmerican-vs-Asian |
1.694760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
4.002800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.177240E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.997610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.314200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.571600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.899400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.957200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.748800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.033870E-02 |
| Classical-VS-Follicular |
5.883800E-01 |
| Classical-VS-Other |
9.694000E-01 |
| Classical-VS-Normal |
4.1044945220392E-13 |
| Tall-VS-Follicular |
6.946200E-02 |
| Tall-VS-Other |
4.164600E-01 |
| Tall-VS-Normal |
1.65600866353088E-12 |
| Follicular-VS-Other |
8.908600E-01 |
| Follicular-VS-Normal |
8.00304267301044E-12 |
| Other-VS-Normal |
1.561540E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
7.54951656745106E-15 |
| N0-vs-N1 |
2.543000E-01 |
|
|
